Collagen is a structural protein that provides mechanical stability and defined architectures to skin. In collagen-based skin disorders like Epidermolysis bullosa, EDS the ability to offer such stability is lost either due to mutations in collagens or defect in the chaperones involved in collagen assembly, which leads to chronic wounds, skin fragility, and blisters. Existing approaches to study and develop therapy against such conditions are the use of small molecules like 4-phenylbutyrate (4-PBA) or growth factors like TGF-β. However, these approaches are not collagen specific resulting in unsolicited responses. Therefore, a collagen specific booster is required to guide the correct folding and deposition of collagen in a highly regulated manner. Hsp47 is a chaperone with a major role in collagen biosynthesis.
Introduction
Collagen fibers represent 60-80% of skin dry weight and confer skin its resistance to mechanical stress [1] [2] [3] [4] . The skin is a layered tissue, and the collagen composition and morphology of each layer is different [5, 6] . COL I is predominant in the dermal and hypodermal layer, and forms heterotypic structures with other collagens such as COL III and/or V [7] . The basement membrane separating the epidermis and dermis is rich in COL IV. In multiple skin pathologies collagen organization is altered, either genetically or acquired due to environmental factors.
Genetic collagen-related skin disorders such as Epidermolysis bullosa (EB) [8] and Ehlers-Danlos Syndrome (EDS) are both caused due to mutations in fibrillar COL I [9] and/or COL III [10] . The patients have fragile skin, blisters and chronic wounds as consequence of reduced collagen levels in the skin tissue due to collagen miss folding, impaired formation of highly organized structures, poor collagen crosslinking, and accelerated collagen degradation [11] .
Scurvy and Aging have localized wrinkles and blisters due to weakening of skin structural architecture between dermis and epidermis due to sparse collagen fiber density and extensive degradation of fibrillar collagen, mostly COL I [12, 13] by matrix metalloproteinase [14, 15] .
The existing therapies for these disorders are based on the delivery of growth factors (e.g. TGFbeta [16, 17] ) and chemical stimulants (e.g. ascorbic acid [17] [18] [19] , glycolic acid [20] , 4-phenyl butyric acid (4-PBA) [21] and retinol [22] ) to boost the collagen production and matrix deposition. However, these molecules have multiple other roles in the body and the therapies are associated with negative side effects, such as promoting abnormal angiogenesis, or inflammatory responses.
We recently demonstrated that uptake of exogenous Hsp47 could specifically enhance collagen deposition in fibroblast cultures [23] . Uniquely, Hsp47 is a collagen-specific chaperone. It has multiple roles in collagen biosynthesis, i.e. it stabilizes triple helical of procollagen [24] [25] [26] [27] [28] , it prevents intracellular procollagen degradation [29] [30] [31] , it is involved in quality control of folded procollagen [31, 32] , it inhibits procollagen aggregate formation in the Endoplasmic Reticulum (ER) [33, 34] , and it supports procollagen transport to Golgi apparatus [30] by binding to procollagen in the ER (at neutral pH) and dissociating in the cis-Golgi (at low pH). The involvement of endogenous Hsp47 in the biosynthesis of collagen subtypes I to V has been reported [23, 29, 35, 36] . It is however unclear if exogenous administration of Hsp47 to cells affects the deposition of each collagen subtype to a similar level, or if deposition of certain collagen is preferentially supported. Note that expression levels of Hsp47 are altered in some variants of EB [37] and EDS [29] and this protein is up regulated in cancer [38] [39] [40] .
Hsp47 is retained in the ER via KDEL receptor mediated transport from the Golgi to the ER [26, 29, [41] [42] [43] [44] [45] . This KDEL-receptor is also found on the cell membrane, [46] and is critical for the transport of exogenous Hsp47 to the ER of cells in vitro by simple incubation with the protein in solution [23] . Expression levels of KDEL receptor at the cell membrane are celldependent [47, 48] . Therefore, Hsp47 uptake and the resulting up regulated collagen expression levels by exogenous Hsp47 might also be cell-dependent.
In the current work we follow-up on our previous demonstration of Hsp47-stimulated deposition of collagen in in vitro in fibroblast cultures [23] , and we quantify the cell-and typespecific collagen deposition (fibrillar collagens I, III, V, network collagen IV, and fibrilassociated collagen XII) after Hsp47 stimulation in in vitro cultures of fibroblasts, epithelial and endothelial cells from skin tissue. Lastly, the increase in the collagen deposition upon repetitive delivery of recombinant Hsp47 was also studied. Our results provide fundamental understanding of the potential of Hsp47 as therapeutic protein.
Results
The uptake of Hsp47 was tested in fibroblast (NHDF from human skin dermis, L929 from mouse adipose tissue and MEF from mouse embryos), epithelial (HaCaT, human epidermal keratinocytes) and endothelial (HDMEC from human dermis) skin cells. A recombinant EGFPtagged Hsp47 (hereafter referred to as H47 [23] ) was used for these studies. The different cell types were seeded at same cell density and incubated with H47 at concentrations between 0.1 µM and 1.0 µM. Incubation with lower H47 concentrations showed no detectable fluorescence signal inside the cells. Cells incubated with >1 µM H47 showed fluorescent aggregates on the surface of the culture plate, indicating that saturation levels of H47 for uptake were achieved and H47 was binding to extracellular collagen deposited by the cells. At the intermediate concentrations accumulation of green fluorescence was detected inside the cells and no aggregates were observed outside of the cells, indicating efficient uptake of H47. The incubation time of 3 h was uptaken from our previous experience [23] .
H47 uptake was visualized by epifluorescence imaging of EGFP green signal inside the cells.
Co-localization of H47 and the ER signals confirmed accumulation of the uptaken H47 at the ER in a cell types (Figure 2b, S1). No fluorescence signal was observed when cells were incubated with EGFP alone, indicating that uptake is specific to the H47 sequence and not mediated by the EGFP label (Figure S1and 2). Our previous work demonstrated that this occurs through KDEL receptor mediated endocytosis and transport [23] . H47 uptake was quantified by counting the percentage of cells with detectable ER-and H47 fluorescent signals after incubation for 3 h and medium change. 100% uptake indicates that all the cells with labeled ER contained labeled H47.
Results show that H47 uptake was concentration dependent, and cell type dependent (Figure 2a ).
An increase in the H47 incubation concentration led to increased uptake, and >80% uptake was observed for fibroblasts and endothelial cells at 0.5 µM H47. Saturation levels are achieved at 0.5 and 0.8 µM H47 for MEF and L929 cells, and at 1 µM H47 for NHDF and HDMECs. HaCaT cells showed the lowest uptake, with maximum uptake values of ca. 80% achieved at >0.8 µM H47 concentrations. This variation is attributed to differences in distribution and density of KDEL receptors on the cell membrane, which has been reported by other authors [46] .
We then compared H47-induced collagen deposition by the different cell types after incubation with 0.5 µM H47. For this purpose, cells were seeded for 24 h on tissue culture plastic wells and incubated with 0.5 µM of H47 for 3h. The medium was exchanged and cells were cultured for further 24h. The deposited collagen on the culture plate was labeled with Picro Sirius Red and quantified by spectrophotometry. Sirius red is a strong anionic dye comprising six sulfonate groups that binds preferentially to the cationic groups of the collagen fibers [49, 50] . Data were normalized by the value of collagen deposition by MEF cells without any treatment. The fibroblast cell lines MEF, L929 and NHDF showed a 70% -100% increases in collagen deposition when treated with H47. Under the same incubation conditions, the epithelial (HaCaT) and endothelial (HDMEC) cell lines showed 20 and 50% increase in collagen deposition respectively ( Figure 3a ). These results indicate that exogenously supplied H47 induces collagen deposition more effectively in fibroblast cells. This is in agreement with the natural role of fibroblasts as major matrix-producing cells in connective tissue [51, 52] .
We followed collagen deposition at increasing culture times up to 14 days. Collagen deposition in Fibroblasts (L929, NHDF, MEF) without H47 treatment increased during the first 6 days and reached a steady state at longer time scales (Figure 3 b, c and d). This trend correlates with proliferation kinetics expected for this cells, and the expected down regulation of matrix production when confluency is reached [53] . Fibroblast cells were 80-100% confluent at day 9-10. HaCaT and HDMEC cells did not show an appreciable increase in collagen deposition with time, and the overall amount of deposited collagen was much lower ( Figure 3 e and f). When cultures were treated with H47 on day 1, the total amount of deposited collagen at least doubled on day 1, but the collagen deposition profile at longer times did not change significantly, i.e. the curve was just shifted to higher collagen values from day 1 ( Figure 3 ). This result is in agreement with the expected life time of H47 (more than 24h for natural Hsp47 at physiological conditions [23, 54] ). In addition, these results indicate that the collagen deposited after H47 treatment has similar stability to the naturally deposited collagen without H47 stimulation.
We then tested if the amount of deposited collagen could be further increased by repetitive delivery of H47 on consecutive days. Culture medium was supplemented with 0.5 µm H47 on days 1, 3, 6, 9 and 12, and collagen deposition was quantified on days 1, 3, 5, 7, 10 and 14. A 2-3fold increase in collagen deposition was observed in NHDF, MEF and L929 cells after repeated treatment with H47 until day 5. HaCaT and HDMEC cells showed 1-1.5fold increase in collagen deposition within the same timescale. Addition of H47 on days 6, 9 and 12 did not The composition of the collagen matrix is tissue-dependent and different cells are expected to produce different collagen types. We investigated if Hsp47-induced collagen had the same composition as the naturally secreted collagen. For this purpose, H47-treated cultures were decellularized and the remaining matrix layer on the culture plate was stained using antibodies specific for COL I, III, V and XII. These collagens were selected based on their abundance in skin tissue and their involvement in skin related disorders, in which they are reduced or mutated [9-11, 22, 52] . The relative abundance of each collagen subtype was obtained from the observed in the deposition of COL XII, suggesting that Hsp47 may not be involved in the secretion of the fibril-associated COL XII. We observed that cell spreading increased in cultures treated with Hsp47, which is an expected finding as collagen is a matrix protein with multiple adhesion sites for the integrin family.
We also studied the influence of exogenously supplied H47 on collagen production in a previously established MEF Hsp47-knockout fibroblast cell line (Hsp47-/-), which does not produce endogenous Hsp47 [59] [60] [61] . Deposition of fibrillar COLs I, III and V increased upon H47 treatment. No increase in COL IV and XII was observed, in agreement with previous observations in the other fibroblast cell lines (Figure5 a, c, S4). In order to quantify deposited collagen subtypes at higher sensitivity, western blot analysis of the deposited matrix was performed. Higher deposition of COL I, III and V was confirmed, and a very low amount of COL IV was also detected. Interestingly, similar analysis performed with healthy MEF cells (Hsp47+/+) revealed that these cells produced these collagen types to similar extent as observed in Hsp47-/-cells after H47-induction ( Figure 5b ). These results demonstrate that treatment of H47 deficient cells with exogenous H47 restores the ability of the cells to deposit collagen at levels and composition similar to healthy cells. Taking into account the physiological relevance of matrix composition and properties in cellular behavior in vivo we speculate that treatment with Hsp47 could be a useful approach to enhance collagen synthesis and matrix deposition ondemand.
Discussion
Hsp47 is a collagen-specific chaperone protein with multiple roles in collagen biosynthesis.
Expression levels of Hsp47 correlate with collagen production [59, 62] . Hsp47 has a regulatory role during scar formation in neonatal mouse skin after injury, which indicates that its expression during healing is up regulated in situ, in response to injury [63] . These facts indicate that Hsp47 could be an interesting therapeutic target in collagen-related skin disorders, as alternative to non-specific collagen inducers such as TGF β [64] , VEGF [65] or ascorbic acid [17, 18] . Therapeutic use of these molecules to enhance collagen deposition influences other cellular functions such as proliferation [17, 18, 66, 67] , differentiation [66] and angiogenesis [68] , leading to undesired side effects. For example, ascorbate increases collagen production by acting as a co-factor to proline and lysine hydroxylases, which are involved in the hydroxylation of procollagen [42] . However, these enzymes are also involved in the hydroxylation of other matrix proteins, like Elastin or Fibronectin [69] . In contrast, the unique collagen-specificity of Hsp47, demonstrated in the literature [23, 29, 49] , would allow up regulation of collagen deposition, without affecting any other molecule or cellular pathway.
The deposition of fibrillar collagens I and II, and to a less extent fibrillar collagen V was mainly enhanced in all tested cell types. Deposition of network COL IV was only observed in cells that are naturally connected to a basement membrane, where COL IV is also a major component.
Fibril-associated COL XII was not enhanced by H47 treatment. The significant enhancement of fibrillar collagen deposition vs. other collagen types highlights the supporting role of Hsp47 in the intracellular assembly, stabilization and transport of collagen superstructures. A fibrillar collagen specific stimulation of collagen production could be a positive aspect for a potential Hsp47-derived therapy to enhance natural collagen production in diseases.
It is interesting to compare the efficiency of Hsp47-based enhancement in collagen deposition vs. treatment with other collagen inducers from literature data. In the comparison both the amount of deposited collagen and the time scale at which noticeable deposition occurred is relevant. We anticipate that the comparison is done among different cell types and culture methods and, therefore, numbers can only be taken as indicative. In our data, the deposition of fibrillar COLs I and III in fibroblasts (MEF, L929 or NHDF) was enhanced up to 70% -100% in 24 h. In contrast, ascorbate treatment of primary healthy skin fibroblast increased collagen production by 20-40 % after 4 days of treatment in vitro (measured by radioactively labeling procollagen), [70] and only 10 % in Hsp47 deficient fibroblast (measured by Sirus red assay) [23] . Glycolic acid treatment increased collagen production by 48% in a week in human skin fibroblast culture from neonatal foreskin and outgrown cells [71] and Vitamin A (retinol) induced a 100% increase in chronological aging skin in human patients in vivo after 24 weeks[72]. This comparison reveals that Hsp47 promotes fast and efficient deposition of fibrillar collagen in comparison with the other molecules, which would be a beneficial feature for a therapeutic use of Hsp47.
In vivo collagen assembles into high order structures [73] . In 2D cultures the interaction of the secreted collagen with the polystyrene plate affects the assembly [74] . Studies in real tissues would be necessary to proof if the secreted collagen upon Hsp47 treatment is able to form morphologically complex structures as it occurs in the natural extracellular matrix.
Conclusions
The collagen subtype distribution in natural tissue plays a crucial role in tissue biomechanics, and alterations result in pathological states. In the skin, alterations in collagen levels are present in EDS, EB or Scurvy, and lead to chronic wounds, blisters and skin fragility. Our results show that exogenous delivery of Hsp47 chaperone can enhance collagen deposition in a cell-specific manner. Being a collagen specific molecular chaperone, Hsp47 treatment is not expected to affect other cellular process, unlike other collagen-stimulators like ascorbic acid, glycolic acid, retinol or growth factors would do. This is a relevant advantage Hsp47 for its potential use as matrix-stimulating therapeutic protein.
Materials and methods

Synthesis and Purification of H47
EGFP-Hsp47 (H47) was synthesized and purified using previously established protocol [23] .Pre-inoculums of H47 were grown overnight in LB medium containing NaCl 
Quantification of H47 uptake by different cell types
Imaging of the cell cultures was performed using a Nikon Ti-Ecllipse microscope (Nikon Instruments Europe B.V., Germany) with a 60X objective. The number of cells showing both H47 signal with ER tracker signal were counted and represented in percentage. Maximum of 100% was considered if all cells showed EGFP green signal from H47 with ER signal. This analysis was performed on all cell types. All the analysis was done using Image J and graphs were plotted using graph prism software for three independent experiments for each cell types.
Sirus Red Assay for quantification of Collagen deposition and Immuno-staining
Cells were cultured in 24 well plate for 24 hours (50K cells per well). Cells were incubated with 0.5 µM solutions of H47 in DMEM and M199 medium for 3 h, followed by medium exchange and cultured for 1, 3, 5, 7, 10 and 14 days. Non treated cells were cultured for similar time points and used as controls in this experiment. For testing repeated H47 treatments in all the cell types, H47 was also added on day 1, 3, 6, 9 and 12. Collagen deposition was quantified on days 1, 3, 5, 7, 10 and 14 by Sirus Red assay as mentioned above. For Sirius Red assay cells were fixed using Bouin solution (75% picric acid, 10% formalin, and 5% acetic acid) (Sigma HT10132). Collagen deposited in the wells was stained by incubating with 0.1% Sirius red in picric acid (ab150681) for 1 h and washing with 0.01 N HCl. The matrix was dissolved in 0.1 N NaOH and the absorption of the slurry were measured at 570 nm using a Biolumin960k spectrophotometer [23, 49] . The absorbance values (Figure 3a in manuscript) were normalized by the value of collagen deposition from untreated MEF cells in 24h. In MEF Hsp47 -/untreated cells were considered as 1 for Figure 4a .
For testing ability of H47 to enhance collagen deposition on cells reaching confluency, L929
were seeded at a high density (50 cells/well) and allowed to become confluent within 2 days and treated with H47 and kept for 24h after treatment. Collagen deposition was quantified using sirus red assay as mentioned above. The absorbance values were normalized by the value of collagen deposition from untreated L929 cells in 24h as 1. Also deposited collagen was stained with COL 1 antibody ((Rabbit polyclonal anti-type I collagen, 600-401-103-0.1 (Rockland) and secondary antibody (goat anti-Rabbit IgG (H+L) Highly Cross-Adsorbed Secondary Antibody, Alexa Fluor 647, A-21245 (dilution 1:200) to visualize H47-bound to collagen.
For immunostaining, the cultures were decellularized using a previously established protocol [75] , fixed using 4% PFA and stained with Collagen-specific antibodies. Cultures were treated with 0.5% Triton X-100 and 20mM NH4OH for 5 min at 37 °C for decellularization. The Results were normalized by taking untreated MEF cells as 1. In MEF Hsp47 -/-untreated cells were considered as 1. This analysis was performed in Image J.
Western Blot to study increase in collagen subtypes on treatment with H47 in MEF
Hsp47 -/-cells.
Deposited collagen from cells cultured in the presence and in the absence of H47 was suspended in 300 µL of RIPA Buffer. Before this step, the collagen deposited was decellularized using the above-mentioned protocol. Protease inhibitor and Lameli buffer (4x stock concentration) was added in mixture to avoid protein degradation. The samples were loaded into SDS-PAGE gels.
The 12% SDS PAGE gels were transferred using blotting chamber to PVDF membranes. The 
Statistical significance
For Sirus Red assay (n=6) number of experiment were performed and plotted with graphs including whisker plots representing standard deviation for MEF, L929, NHDF, HTCAT and HDMEC. For MEF Hsp47 -/-three independent experiments were performed. For immunostaining quantification IMAGE J was used to quantify mean intensity profile of stained matrices in all cell types treated with and without H47 with bar plots including error bars indicating standard deviation. In both assays the data were normalized with respect to collagen deposited in MEF untreated as 1. In case of MEF Hsp47 -/-untreated cells were considered as 1. Statistical significance was analyzed by Tukey test, which shows significant differences between conditions. Significance was calculated by comparing non treated vs treated cells (mean±SD, ANOVA, *** p<0.001). 
